| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,045 |
2,897 |
$652K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,383 |
1,300 |
$249K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,267 |
1,221 |
$223K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,359 |
778 |
$198K |
| 80053 |
Comprehensive metabolic panel |
2,454 |
2,184 |
$195K |
| 36415 |
Collection of venous blood by venipuncture |
2,300 |
2,075 |
$193K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,261 |
1,177 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
817 |
797 |
$151K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
636 |
616 |
$141K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
360 |
351 |
$109K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
425 |
425 |
$64K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
66 |
65 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,222 |
1,159 |
$56K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
158 |
142 |
$54K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,415 |
2,947 |
$52K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
368 |
368 |
$51K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,223 |
1,178 |
$40K |
| 81025 |
|
302 |
294 |
$33K |
| 80061 |
Lipid panel |
396 |
394 |
$21K |
| 99215 |
Prolong outpt/office vis |
155 |
147 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
327 |
319 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
215 |
213 |
$12K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52 |
52 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
185 |
166 |
$11K |
| 97161 |
|
90 |
90 |
$10K |
| 83735 |
|
1,294 |
1,099 |
$8K |
| 80051 |
|
272 |
259 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,052 |
929 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
299 |
295 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
48 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26 |
26 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
126 |
125 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
238 |
140 |
$3K |
| 82565 |
|
458 |
439 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
521 |
451 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$2K |
| 85027 |
|
96 |
92 |
$2K |
| 81001 |
|
951 |
890 |
$2K |
| 87634 |
|
37 |
36 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
32 |
31 |
$1K |
| 83690 |
|
964 |
897 |
$881.60 |
| 0012A |
|
28 |
28 |
$764.10 |
| 0011A |
|
28 |
28 |
$760.10 |
| 84520 |
|
311 |
296 |
$758.29 |
| 84450 |
|
158 |
149 |
$688.37 |
| 73630 |
|
12 |
12 |
$643.50 |
| 81003 |
|
293 |
281 |
$505.31 |
| 82947 |
|
307 |
294 |
$483.43 |
| 82607 |
|
13 |
13 |
$376.70 |
| 84484 |
|
203 |
170 |
$308.66 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
18 |
$207.26 |
| 71045 |
Radiologic examination, chest; single view |
17 |
15 |
$163.98 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25 |
24 |
$117.77 |
| 85652 |
|
12 |
12 |
$96.40 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
533 |
494 |
$92.14 |
| 82550 |
|
14 |
14 |
$70.08 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
121 |
110 |
$63.14 |
| J3490 |
Unclassified drugs |
24 |
21 |
$51.83 |
| 82040 |
|
101 |
92 |
$22.54 |
| 82247 |
|
102 |
93 |
$16.94 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
405 |
353 |
$2.75 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
169 |
155 |
$0.16 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
51 |
42 |
$0.00 |
| 80320 |
|
14 |
12 |
$0.00 |